Identification of a glioblastoma-associated Tenascin-C isoform by a high affinity recombinant antibody

American Journal of Pathology

Volumn 154, Issue 5, 1999, Pages 1345-1352

  Carnemolla, Barbara ^a   Castellani, Patrizia ^a   Ponassi, Marco ^a   Borsi, Laura ^a   Urbini, Stefania ^a   Nicolo, Guido ^a   Dorcaratto, Alessandra ^d   Viale, Giuseppe ^d   Winter, Greg ^b   Neri, Dario ^b,c   Zardi, Luciano ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c ETH ZURICH   (Switzerland)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; RECOMBINANT ANTIBODY; TENASCIN;

ALTERNATIVE RNA SPLICING; ARTICLE; ASTROCYTOMA; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MELANOMA; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032932980     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65388-6     Document Type: Article

References (40)

1. Folkman J: Angiogenesis in cancer, vascular, rheumathoid and other diseases. Nat Med 1995, 1:27-31
2. Van den Hoff A: Stromal involvement in malignant growth. Adv Cancer Res 1988, 50:159-196
3. Risau W, Lemmon V: Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Devel Biol 1988, 125:441-450
4. Ingber D, Folkman J: How does extracellular matrix control capillary morphogenesis? Cell 1989, 58:803-805
5. Borsi L, Carnemolla B, Nicoló G, Spina B, Tanara G, Zardi L: Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int J Cancer 1992, 52:688-692
6. Kaczmarek J, Castellani P, Nicoló G, Spina B, Allemanni G, Zardi L: Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int J Cancer 1994, 58:11-16
7. Leprini A, Querzè G, Zardi L: Tenascin isoforms: possible targets for diagnosis and therapy of cancer and mechanisms regulating their expression. Perspect Devel Neurobiol 1994, 2:117-123
8. Carnemolla B, Neri D, Castellani P, Leprini A, Neri G, Pini A, Winter G, Zardi L: Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domain. Int J Cancer 1996, 68:397-405
9. Riva P, Arista A, Sturiale C, Moscatelli G, Tison V, Mariani M, Seccamani E, Lazzari S, Fagioli L, Franceschi G, Sarti G, Riva N, Natali PG, Zardi L, Scassellati GA: Treatment of intracranial human glioblastoma by direct intratumoral administration of 131 I-labelled anti-tenascin monoclonal antibody BC-2. Int J Cancer 1992, 51:1-7
10. Neri D, Carnemolla B, Nissim A, Leprini A, Querzè G, Balza E, Pini A, Tarli L, Halin C, Neri P, Zardi L, Winter G: Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform. Nat Biotech 1997, 15:1271-1275
11. 111 In-labelled SCN-bz-DTPA-BC-2 Mab following loco-regional injection into glioblastomas. Int J Cancer 1997, 71:810-816
12. Chiquet-Ehrismann R: Tenascin and other adhesion-modulating proteins in cancer. Semin Biol 1993, 4:301-310
13. Erickson HP, Bourdon MA: Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu Rev Cell Biol 1989, 5:71-92
14. Edelman GM, Jones FS: Cytotactin-a morphoregulatory molecule and a target for regulation by homeobox gene products. Trends Biochem Sci 1992, 17:228-232
15. Erickson HP: Tenascin-C, Tenascin-R and Tenascin-X: a family of talented proteins in search of functions. Curr Opin Cell Biol 1993, 5:869-876
16. Gherzi R, Carnemolla B, Siri A, Ponassi M, Balza E, Zardi L: Human tenascin gene. J Biol Chem 1995, 270:3429-3434
17. Gulcher JR, Nies DE, Marton LS, Stefanssonn K: An alternatively spliced region of the human hexabrachion contains a repeat of potential N-glycosylation sites. Proc Natl Acad Sci USA 1989, 86-1588-1592
18. Siri A, Carnemolla B, Saginati M, Leprini A, Casari G, Baralle F, Zardi L: Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies. Nucleic Acids Res 1991, 19:525-531
19. Sriramarao P, Bourdon MA: A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices. Nucleic Acids Res 1993, 21:163-168
20. Mighell AJ, Thompson J, Hume WJ, Markham AF, Robinson PA: Human tenascin-C: Identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae. Int J Cancer 1997, 72:236-240
21. Borsi L, Balza E, Castellani P, Carnemolla B, Ponassi M, Querzé G, Zardi L: Cell-Cycle dependent alternative splicing of the tenascin primary transcript. Cell Adhes Commun 1994, 1:307-317
22. Borsi L, Balza E, Gaggero B, Allemanni G, Zardi L: The alternative splicing pattern of the tenascin-C pre-mRNA is controlled by the extracellular pH. J Biol Chem 1995, 11:6243-6245
23. Borsi L, Allemanni G, Gaggero B, Zardi L: Extracellular pH controls pre-mRNA alternative splicing of tenascin-C in normal, but not in malignantly transformed cells. Int J Cancer 1996, 66:632-635
24. Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR: Making antibodies by phage display technology. Annu Rev Immunol 1994, 12: 433-455
25. Vaughan TJ, Williams AJ, Pritchard K, Osbourn JK, Pope AR: Earnshaw JC, McCafferty J, Hodits RA, Wilton J, Johnson KS: Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phages display library. Nat Biotechnol 1996, 14:309-314
26. Aukhil I, Joshi P, Yan Y, Erickson P: Cell- and heparin-binding domains of the hexabrachion arm identified by tenascin expression proteins. J Biol Chem 1993, 268:2542-2553
27. Balza E, Siri A, Ponassi M, Caocci F, Linnala A, Virtanen I, Zardi L: Production and characterization of monoclonal antibodies specific for different epitopes of human tenascin. FEBS Lett 1993, 332:39-43
28. Carnemolla B, Balza E, Siri A, Zardi L, Nicotra MR, Bigotti A, Natali PG: A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J Cell Biol 1989, 108:1139-1148
29. Castellani P, Viale G, Dorcaratto A, Nicolè G, Kaczmarek J, Querzé G, Zardi L: The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer 1994, 59:612-618
30. Schaeren-Wiemers N, Gerfin-Moser A: A single protocol to detect transcripts of various sizes and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes. Histochemistry 1993, 100:431-440
31. Ponassi M, Jacques ST, Ciani L, ffrench-Constant C: Expression of the rat homologue of the Drosophila fat tumour suppressor gene. Mech Dev 1999, 80:207-212
32. Riva P, Arista A, Tison V, Sturiale C, Franceschi G, Spinelli A, Riva N, Casi M, Moscatelli G, Frattarelli M: Intralesional radio-immunotherapy of malignant gliomas. Cancer 1994, 73:1076-1082
33. Bourdon MA, Wikstrand CJ, Furthmayr H, Matthews TJ, Bigner DD: Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res 1983, 43:2796-2805
34. Riva P, Franceschi G, Arista A, Frattarelli M, Riva N, Cremonini AM, Giuliani G, Casi M: Local application of radiolabeled monoclonal antibodies in the treatment of high grade malignant gliomas. Cancer 1997, 80:2733-2742
35. 99mTc]PnAO-biotin. Eur J Nuclear Med 1994, 21:314-321
36. Carnemolla B, Siri A, Borsi L, Zardi L: Tenascin in disease. Tenascin and Counteradhesive Molecules of the Extracellular Matrix. Edited by KL Crossin. Amsterdam, Harwood Academic Publishers, 1996, pp 89-108
37. Dörries U, Schachner M: Tenascin mRNA isoforms in the developing mouse brain. J Neurosci Res 1994, 37:336-347
38. Tucker RP, Spring J, Baumgartner S, Martin D, Hagios C, Poss PM, Chiquet-Ehrismann R: Novel tenascin variants with a distinctive pattern of expression in the avian embryo. Development 1994, 120:637-647
39. Yokota T, Milenic DE, Whitlow M, Schlom J: Rapid tumor penetration of single-chain Fv and comparison with other immunoglobulin forms. Cancer Res 1992, 52:3402-3408
40. Yokota T, Milenic DE, Whitlow M, Wood JF, Hubert SL, Schlom J: Microautoradiographic analysis of the normal organ distributions of radioiodinated scFv and other immunoglobulin forms. Cancer Res 1993, 53:3776-3783